全球動物用抗感染藥市場:各動物疾病、技術、動物、地區 - 趨勢及預測
Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2015-2020
|出版商||Mordor Intelligence LLP||商品編碼||319398|
|全球動物用抗感染藥市場:各動物疾病、技術、動物、地區 - 趨勢及預測 Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2015-2020|
|出版日期: 2016年01月01日||內容資訊: 英文||
Global market for veterinary anti-infectives is estimated to be worth $4570 million in 2015. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach $6218 million by 2020. Global veterinary healthcare offers services and products in various segments such as Vaccine, Paraciticides , Anti-Invectives , Medicinal Feed additives , Other Pharmaceuticals out of which anti-invectives is growing at a steady pace to combat the increasing number of infectious diseases in animals.
It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.
The report highlights segment wise contribution of different anti-incentives segments by disease, species and geography to the global veterinary anti-infective market. By type of products like - Marbofloaxcine, Florfenicol, Freeze-dried ceftiofur, Beta-lactams, Oxytetracycline and Amminosidin; By species within companion farm animals and By Geographies like North America, South America, Asia-Pacific, Europe, Middleeast and Africa.
Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global animal anti-infectives market.
Drivers: Increase in pet ownership, Improved Nutrition, Increasing Zoonotic and Foodborne Diseases are the major driving forces which accelerates the global veterinary anti-invectives market
Constraints: Increased competition for cultivated land and Cost effective production happens to be major obstacles in the path of global veterinary anti-invectives market quest.